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In 1956 Grubb (1)  discovered individual differences  in human TG-globulins (7ST) 
detectable by a complex serologic reaction based on the ability of individual T-globu- 
fins to inhibit the interaction of selected anti-T-globulins with TG-incomplete anti-Rh 
antibodies, coating Rh0+ erythrocytes. This finding led to the subsequent delineation 
of several genetically controlled variants of human TG-globufins, collectively known 
as the Gm factors (2).~ In spite of the complex assay system required for their detec- 
tion, and as yet incomplete knowledge of their precise mode of inheritance  (3, 4), a 
great deal is known about their molecular localization. The Gm factors are present 
only on certain types of heavy polypeptide chains of IgG (T-chains), and not found in 
the IgA and IgM fractions (5--8). The Gin(a) and Gin(b) factors are found in the Fe 
fragment of the T-chain (5, 6) while Gin(f) activity appears to be located in the Fd 
fragment (9). 
The  precise  mode  of inheritance  of the  Gm  factors is  controversial.  Population 
studies suggest that the Gm factors are determined by multiple codominant alleles at 
the  Gin locus. They are phenotypically recognizable as a  series  of serologically de- 
tectable factors; of these, those studied in greatest detail to date are Gin(a)  [Gin(l)], 
Gin(b) [Gm(5)], and Gin(f) [Gin(4)]  (2). A large number of additional Gm factors have 
been described during the past 10 yr, and new ones are being found with increasing 
frequency. Two of these  Gin(y)  and  Gin(z),  are of greatest immediate  significance 
since they appear to be under the control of the alleles  of Gm  a and Can  t respectively 
(10). 
The discovery of several antigenically distinguishable subgroups of T-chains, each 
associated with different Gm factors, has led to another theory of their inheritance (4), 
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715 716  HUMAN  ~tG-MYELOMA  PROTEINS 
namely that a series of closely linked loci exist, each associated with one of these sub- 
groups. These -/-chain subgroups have been termed We, Vi, Ne, and Ge by Grey and 
Kunkel (11), and -/2b, -/2¢, -/~, and ~'~d in an alternate terminology by Terry and Fahey 
(12). According to this hypothesis, the We locus controls the synthesis of the Gm(a), 
(f),(y), and (z) factors; the Vi locus that of Gm(b) and  the recently described  Gin(g) 
[21] (3,8) factor; and the Ne and Ge loci determine the elaboration of genetic  factors 
that have yet to be identified  (4). Neither concept (a single locus or four loci)  satis- 
factorily explains all of the serologic and biochemical data presently  available.  Ac- 
cordingly,  the present studies were designed  to provide additional  data  correlating 
some structural features with the serologic (Gin) differences and the antigenic hetero- 
geneity of the -/-chains of the human IgG fraction. 
Previous studies of peptide maps of -/-globulins from normal Caucasian individuals 
who were Gm(a +b-),  Gm(aTb +), or Gm(a-b +) have dearly demonstrated cer- 
tain characteristic differences related to the Gm type (13-16). The subsequent identifi- 
cation of a new Gin factor, Gin(f) [4] or (bw) [3], (17,  18), which is universally present 
in those Caucasians who are Gin(b+) but does not occur in Negroes aU of whom are 
Gm(b +), has clearly pointed out the limitations of studies of normal -/-globulins from 
a  single  ethnie  group.  Furthermore,  isolated  -/G-preparations,  even from a  homo- 
zygous subject, consist of mixtures of at least four subclasses of IgG and may carry, 
in addition to the currently recognized Gin factors, other genetic markers which have 
not yet been delineated.  Since the more homogeneous proteins produced by patients 
with neoplastic dyscrasias of plasma cells (myeloma proteins) consist of only a single 
type of -/-chain (11,  12) and usually carry no more than one of the genetic markers, 
Gin(a) [1], (b) [5], or (f) [4] (4, 7), it seemed probable that study of such proteins would 
provide more definitive information on the structural variations of -/-globulins differing 
in Gm type. 
The present study presents  the results of peptide map analyses of 36 mye- 
loma proteins  and  two  "heavy chain  disease"  proteins  of the  four  major "r- 
chain subtypes and including proteins that were phenotypically  Gm(a+b--f--), 
Gin(a--b--f+),  Gin(a--b--f--), and Gm(a-b-bf--).  In addition,  the  results 
of amino  acid  analyses of some of the  peptides  characteristic  of Gin(a),  (b), 
and (f), and (--) molecules are presented and possible mechanisms for their var- 
iations are suggested. The results of these studies of myeloma proteins confirm 
and,  in several areas, extend  those previously obtained with normal 3'G-glob- 
ulins, and raise a  number of questions about the currently postulated mode of 
inheritance of the Gm factors. 
Materials and Methods 
Isolation  of  Myeloma Proteins and  Normal -/-Globubin.--'tG-myeloma proteins  were 
isolated from sera of 36 patients with multiple myeloma by starch zone electrophoresis  (19). 
Two additional  proteins  (Zuc; Cra) obtained from patients with "heavy chain disease", were 
isolated  from the urine.  Purity was determined  by immunoelectrophoresis,  using  antisera 
specific for each class of immunoglobufin. In most preparations, only a single type of fight or 
-/-ehain was seen  on  immunoelectrophoresis,  and  contaminating normal T-globulin  never 
exceeded 10% of the total protein. :FRANGIONE, ~FRANKLIN, ]FUDENBERG, AND  KOSHLAND  717 
Antigenic  Typing.--The four major subtypes of T-chains were determined by agar double 
diffusion with antisera prepared to a myeloma protein or heavy chain disease  protein  belonging 
to each class and rendered class-specific by absorption with a pool of myeloma proteins of the 
other three classes and Bence-Jones proteins of Type k and )~. 
Gm typing was performed by standard inhibition of agglutination techniques, exactly as 
described previously (20).  Myeloma proteins were tested at concentrations of 2.5,  0.6,  and 
TABLE I 
Summary of 38 Mydoma Proteins Studied 
Name  7-chain 
subclass 
Lew  We(T2b) 
Tru  "  " 
Mac  "  " 
Hic  "  " 
Bur  "  " 
Dee  "  " 
Chu  .... 
Cab  "  " 
Pre  "  " 
Nag  "  " 
Fri  "  " 
Coo  "  " 
Schw  ~  ~c 
Bre  "  " 
Sch  .... 
Vog  "  " 
Bor  "  " 
Bac  "  " 
Burr  "  " 
Fm  "  " 
cra  §, I1! ..... 
Race*  Gm  ty~t 
W  a+ 
W  a+ 
P.R.  a+ 
N  a+ 
N  a+ 
N  a+ 
N  a+ 
N  a+ 
W  f+ 
W  f+ 
W  f+ 
W  f+ 
W  f+ 
W  f+ 
W  f+ 
W  f+ 
W  f+ 
N  f+ 
N  f+ 
N  f+ 
N  (-) 
Name  7-chaln 
subclass 
Gla  vi(T~o) 
Cha  "  " 
Mai  "  " 
Bur  "  " 
Nie  "  " 
Fel  "  " 
Zucll  .... 
Sha  "  " 
Mar  "  " 
Hof  Ne(7~) 
Wat  "  " 
Lew  "  " 
Erw  "  " 
Dun  Ge(T~d) 
Wur  "  " 
Moo  "  " 
Race  ~  Gm  type~ 
W  b+ 
W  b+ 
W  b+ 
W  b+ 
w  (-) 
w  (-)  (g+) 
W  b+ 
W  b+ 
N  b+ 
N  b+ 
W  (-) 
W  (-) 
N  (-) 
N  (-) 
W  (-) 
W  (-) 
W  (-) 
* N, Negro; W, White; and P.R., Puerto Rican. 
:~ Gm a,  b,  and  f  tested. Positive results listed. Only Vi was tested for Gm(g). 
§ The precise antigenic type is difficult  to determine. It most closely resembles the We 
subtype though it has been previously classified  as Ge (7). 
[] "Heavy  Chain"  Disease. 
0.15 mg/ml. 'qnhlbitors" gave clear inhibition at the lowest concentration while "nonlnhlbi- 
tots" failed to inhibit at the highest one. 
Preparation  of Fc Fragments.--Fc  fragments were prepared from myeloma proteins with 
papain, EDTA, and cysteine exactly as described (21), and separated from the Fab fragments 
by adsorption to DEAE-cellulose at pH 8, g 0.01 and elution with 0.3 ~ NaCI pH 8. Digestion 
was allowed to proceed for 18 hr in the case of the Ge and We proteins, 24 hr in the case of Ne 
molecules, and 1 to 4 hr in the case of Vi molecules because of the known lability of their Fc 
fragment to papain digestion (22, 23). Fc fragments were prepared from all the We(T2s)  and 
Ge(Tsd) myeloma proteins. Because of their rapid eleetrophoretic mobility, two of the latter 
were isolated by starhch zone electroporesis. Only six Vi(T~o  ) proteins yielded sufficient Fc 718  HUMAN  "/C,-MYELOMA PROTEINS 
fragments to permit their isolation. Insufficient  amounts of protein were available to prepare 
Fc fragments from two of the Ne(h'~) proteins.  In two others, papain digestion was incom- 
plete, and the Fc fragment could not be separated from the Fab fragment and residual partially 
digested myeloma protein. Purity of Fc fragments was checked by immunologic techniques 
The naturally occurring Fc fragments from two patients with heavy chain disease were used as 
such.  Patient Zuc belonged to the Vi class and was Gm(b+)  (4).  Cra, though previously 
reported as belonging  to  the  Ge(h'2a)  subclass  (7)  was difficult  to classify but resembles 
We (~/2b) molecules most closely antigenically  and by peptide mapping. 
Preparation of Heavy Chains.--Heavy chains were prepared from  each of the myeloma 
proteins by reduction in Tris pH 8.2, 0.55 ,J buffer with 0.75 M mercaptoethanol, followed by 
the addition of an equal amount of iodoacetamide. Heavy and light chains were separated on 
Sephadex G-100 in 1 ~ propionic acid (24). Purity was checked by Ouehterlony  analysis with 
antisera to "r-chains and light chains. 
Fingerprinting.--Two dimensional chromatography and electrophoresis  of trypsin digests 
was done (25), using performic acid oxidized preparations. The details of the procedure have 
been described (13). 
Amino Acid Analyses.--In order to obtain sufficient amounts of peptides for amino acid 
analyses, eight to twelve peptide maps were prepared under identical conditions.  One was 
stained with ninhydrin and used as a reference pattern. The appropriate spot in  the same 
position in the unstained maps was cut out from each of the others and eluted with distilled 
water and dried on an Evapo mix (Buchler Instruments, Inc., Fort Lee, New Jersey). The 
rest of the paper was then stained with ninhydrin as a check of the purity of the spot. Each 
amino acid analysis was performed on the pooled eluates obtained from six to twelve maps. 
Each peptide was subjected to acid hydrolysis in 6 ~ HC1 at 105°C for 24 hr in sealed glass 
vials,  and amino acid analyses were  done on a  Beckman  Spinco auto analyser, Beckman 
Instruments, Inc., Palo Alto, California,  according to the method of Spackman,  Stein, and 
Moore (26). 
RESULTS 
Table I  lists the antigenic "/-chain subtype and the Gm type of the proteins 
studied. None of the myeloma proteins was positive for more than one of the 
factors Gin(a), (b), or (f), and a number were negative for all three. Reagents to 
test for Gin(y) and (z) were not available (10). However, it seems likely that all 
Gin(a+)  molecules  were  also  Gin(z+)  and  that  Gin(f+)  proteins  were 
Gin(y+). 
Peptide Maps of Gin(a+) We Myeloma Proteins.--The overall appearance of 
each of the peptide maps of Fc fragments of eight Gin(a+)  myeloma proteins 
was strikingly similar. Each of the fingerprints had about 25 dark and several 
lighter peptides. One peptide, encircled in Fig.  I  a,  and previously correlated 
with Gin(a) in normal "/-globulins, was present in all of the maps; this peptide 
was absent in all the maps of Fc fragments prepared from Gin(a--) myeloma 
proteins or from "/G-globulin from normal  Gin(a--)  subjects.  In addition to 
this major variable, which correlated with Gin(a) positivity or negativity, other 
minor differences were noted. For example, peptlde maps of three proteins (Bur, 
Dee, and Hic), all obtained from Negro donors, had an extra small spot close to 
the Gin(a) peptide which could not be related to the other minor  Gm  factors 
(Fig. 1 b). One of these (Hic) was Gin(c+) while the other two were Gin(c--). FRANGIONE,  FRANKLIN,  FUDENBERG,  AND  KOSHLAND  719 
In addition, the peptide map of Dee lacked three peptides usually seen in the 
area above the  Gm(a)  spot.  Similar results were obtained in  three of twelve 
peptide maps from Fc fragments from normal Gm(a~)  donors (13). The sig- 
nificance of this finding is not known, but appears to be related to the differ- 
ences in the susceptibility of heavy chains of different We proteins to the action 
of papain (27). Some variability in peptide maps of We Fc fragments was also 
seen in a group of five to six peptides wilh variable locations and marked with 
arrows in Figs. 1 a and 1 c. In this region, the peptide marked by the arrow was 
prominent in each of the twelve Gm(a--f~) We maps, but seen in only three of 
eight  of  the  peptide  maps  prepared  from  Gm(an  u)  We  proteins  (Fig. 1 c). 
In  contrast,  peptide maps  of heavy chains from the same myeloma proteins 
showed no variation in this area. This discrepancy suggests that this, too, may 
be related to the enzymatic digestion with papain. 
Peptide maps  of heavy chains from the eight  Gm(a~-)  We  type myeloma 
proteins,  like  those  of  the  Fc  fragments,  all  contained  the  characteristic 
"Gin(a)" spot. The map of the H chains of Dee, like that of the Fc fragment of 
Dee, lacked the three peptides above the Gin(a) spot. In Dee, the other area of 
variability in the middle of the map was not present. However, this region in 
maps prepared from heavy chains, as well as the region near the "a" spot (which 
showed an extra peptide in  two of the Negro Fc fragments),  are difficult to 
evaluate due to the variability in the "Fd piece" of different myeloma proteins 
demonstrated  previously  (28).  None  of  the  peptide  maps  prepared  from 
Gm(a~)  myeloma proteins contained the  peptide associated  with  Gin(b)  in 
previous studies with normal ~'-globulins.  Thus, the studies with Gin(a-J-) mye- 
loma proteins are in keeping with the results obtained previously with normal 
Gm(a~-) 7-globulins (13). 
Peptide Maps of Gm(f~)  We Myeloma Proteins.--The  peptide maps of the 
Fc fragments of the twelve Gm(f+) myeloma proteins were remarkably similar 
to those of the Gin(a-J-) proteins, since virtually all the peptides were similar 
in location. The major difference was the absence of the "a" spot in each of the 
Gm(f-[-) maps and the presence of another peptide in the maps from Gin(f+) 
proteins which was lacking in the Gm(a+) maps  (Fig.  1 c). For reasons cited 
below,  this  peptide  will  be  called  "non-a"  rather  than  "f".  Fingerprints  of 
heavy chains of the Gm(a-f-[-) myeloma proteins also showed the presence of 
the "non-a"  spot in all of them. A second, less striking and somewhat incon- 
stant area of variability occurred in the middle of the map and is indicated by 
arrows in Figs.  1 a  and  1 c. In this region,  a  peptide,  lacking in five of eight 
Gm(a-[-) Fc fragments, is clearly visible in each of the twelve Gm(fn  u) Fc frag- 
ments. 
Peptide Maps of Gm(a--b--f--) Ge Myeloma Proteins.--Peptide  maps of the 
Fc fragment and heavy chains from three Gm(a--b--f--) myeloma proteins of 
the Ge type clearly differed from all the others in a  number of ways.  Firstly, 720 FRANGIONE~ FRANKLIN:  FUDENBERG~ AND  KOSItLAND  721 
FIG. 1.  Peptide maps of Fc fragments prepared from the following: Fig. 1 a, Gm(a+)  We 
myeloma  (Cab)  showing the characteristic single "a" spot  (O)  and absence of the "non-a" 
spot  (r-7); Fig.  1 b, Gm(a+)  We myeloma (Bur)  showing the extra peptide ((),') next to the 
"a" spot (©); and Fig. 1 c, Gm (f+)  We myeloma (Pre)  showing the "non-a" spot (n)  and 
absence of the "a" peptide  (©). The arrows  (Figs.  1 a and  1 c) point to the peptide present 
in all Gm (f+) and only a few of the Gm (a+) maps. 722  HUMAN  3"G-MYELOMA  PROTEINS 
they lacked both the "a"  spot and the "non-a"  spot,  but each had a  peptide 
which moved somewhat further than the "non-a" spot on chromatography but 
appeared to have the same electric charge as the "non-a" spot (Fig. 2). In addi- 
tion,  they lacked two peptides in the middle of the map and one in the basic 
region which  were prominent  in all  the  Gm(a+),  (b+),  or  (f+)  maps.  The 
FI6.2.  Peptide map of Fc fragments of Ge protein (Dun) showing the absence of the "a" 
spot (O) and "non-d' spot (E2) as well as three other peptides (,:)) characteristic of the Fc 
fragments from We and Vi proteins shown in Figs. 1 and 3. The peptide marked (/k) was 
present in all three proteins. 
heavy chains had eight additional peptides characteristic of the Fd  fragment, 
none of which could be related to the missing ones. 
Peptide Maps of Vi Myeloma Proteins.--Each of the fingerprints of Fc frag- 
ments of four Gm(b+f--) myeloma proteins lacked the "a" peptide and con- 
tained a peptide spot located in the same position as the "non-a" spot, already 
described for Gm(f+) We proteins (Figs.  3 a and 3 b). This "non-a" spot ap- 
peared  identical  to the  spot previously termed  the  Gm(b)  spot in normal 3'- 
globulin (13).  However, since these studies of myeloma proteins show that the FRANGIONE, FRANKLIN,  FUDENBERG: AND  KOSHLAND  723 
same  spot  exists  in  Gin(f+)  proteins  and  certain  proteins  that  are 
Gm(a--b--f-)  (see below), the peptide has been renamed  the  "non-a" spot. 
Furthermore, it is evident that this peptide alone cannot distinguish Gm(b+) 
from Gm(f+) proteins belonging to the We and Vi subclasses as well as certain 
Gm(--) proteins belonging to the Vi and Ne subclasses.  Thus, it is important 
to note that Gm(b+) myeloma proteins differed in the number and location of 
several positively charged peptides at the bottom of the map. When compared 
with We Fc fragments from either Gm(a+) or Gm(f+) proteins, the Gm(b+) 
proteins lack one peptide, differ in the distribution of the spots beneath this 
missing peptide, and contain another small extra peptide at the bottom of the 
map (Figs. 3 a and 3 b). Therefore, the appearance of the group of peptides at 
at the bottom of the maps in Figs. 1 a to 1 c and 3 a and 3 b and the single pep- 
tide  just  above them  generally serve  to  distinguish  We from Vi  heavy (~/) 
chains and Fc fragments. However, there was striking variability also in the 
appearance of this group of basic peptides in different Vi proteins. 
The relation of this area to the "non-a" spots and to the serologic specificity 
of the parent proteins is not known. A fingerprint of the naturally occurring Fc 
fragment obtained from a patient (Zuc) with "heavy chain disease" (29)  con- 
tained the "non-a" peptide and had the same appearance as some of the other 
Gm(b+) proteins at the bottom of the map (Fig. 3 b). Peptide maps of heavy 
chains of ten different Vi myeloma proteins (eight of which were Gin(b+) and 
two Gm(g+)) always contained the "non-a" spot. However, this peptide is not 
as clearly defined in peptide maps of H  chains as in maps of the Fc fragments, 
since in the former the "non-a" area is surrounded by several other peptides 
derived from the variable Fd fragment. The appearance of the  "non-a" spot 
in Vi proteins was variable,  ranging from a  single homogeneous, round dark 
spot (Mai) to a definite doubling in one (Vi) who was Gm(a--g+f--). A num- 
ber of "non-a" spots from other Vi proteins appeared to be doubled, but not as 
distinctly as in Vi. This may be due to incomplete digestion of this peptide (30). 
In general, the greater variability, both in the appearance of the "non-a" and 
the basic peptides at the bottom in the Vi proteins, is consistent also with the 
serologic heterogeneity of Gm(b+) proteins (2, 3, 31). 
Peptide Maps  of Gin(a-b-f--)  Ne  Myeloma Proteins.--Peptide  maps  of 
heavy chains and Fc fragments of four Gm(a--b--f--) myelomas, belonging to 
the Ne type, contained a  peptide in the "non-a" region and  lacked  the  "a" 
spot  (Fig.  4).  Although the fingerprints generally resembled those of the We 
type, they were difficult to interpret since in all the proteins belonging to this 
group only heavy chains or heavily contaminated Fc fragments were available 
for study. This appears to be in part due to the incomplete digestion of these 
proteins even after 24 hr of papain digestion and in part to the rapid mobility 
of the Fab fragment in several of these proteins. 
Amino  Acid  Composition of "a"  and  "non-a"  Peptides.--The  amino  acid 724 FRANGIONE,  leRANKLIN,  FUDENBERG,  AND  KOSHLAND  725 
recoveries obtained after 20 hr of acid hydrolysis of "a" and "non-a" peptides 
are shown in Table II. The data have been expressed as moles of amino acid 
per mole of lysine, the C-terminal residue in both the tryptic peptides. Values 
are given only for those amino acids whose yields were at least 10 % of that ob- 
tained for lysine. 
The "a" peptide was isolated from the Fc fragment of a  Gm(a+) myeloma 
(Chu). Its hydrolysate contained one residue of lysine, aspartic acid, threonine, 
and leucine in addition to one or possibly two residues of glutamic acid. Signifi- 
cant  amounts  of contamination  were apparent in  the  fractional recoveries of 
arginine, serine, proline, and glycine; their presence is consistent with the loca- 
tion of several peptides in close proximity to the "a" spot, some of which may 
have been eluted with the "a" spot. When the "a" peptide from the Fc frag- 
ment of pooled normal ~,-globulin was analyzed, a similar composition was ob- 
served for the  neutral  and  acidic amino acids.  However,  the  amounts  of the 
normal "a" peptide  available were too small to  determine  the  content  of its 
basic amino acids. 
Analyses were carried out on a  representative series of  "non-a"  spots.  The 
peptides  were  isolated  from:  (a)  the  Fc  fragment  of one  Gm(f+)  myeloma 
(Pre);  (b)  the Fc fragment of a  Gm(b+) myeloma (Gla) and the heavy chain 
disease protein  (Zuc);  and  (c)  from the  heavy chain of a  Gm(a--b--f--) Ne 
myeloma (Lew). The results show that the major components in all the "non-a" 
peptides  were  identical,  each  hydrolysate  containing  one  residue  of  lysine, 
methionine sulfone,  and  threonine,  and  two residues of glutamic acid.  Again, 
significant impurities were present; as expected, the amounts of contaminants 
in the peptides prepared from the entire heavy chain were larger than those in 
the peptides prepared only from the Fc portion of the chain. 
On the basis of these amino acid analyses, both the "a" and "non-a" spots 
appear to be pentapeptides which contain three amino acids in common, lysine, 
threonine, and glutamic acid, and differ in the remaining two. The "a" peptide 
is  characterized  by a  residue  of aspartic acid  and  leucine  while  the  "non-a" 
peptide is characterized by a  methionine  and an additional  glutamic acid.  It 
should be emphasized, however,  that any asparagine or glutamine present in 
the peptides would be converted to the corresponding carboxy amino acid after 
acid hydrolysis. Thus, final definition of the amino acid  compositions  of these 
peptides cannot be made until  their amide content has been determined. 
FIO. 3.  Peptide maps of Fc fragments prepared from the following: Fig. 3 a, Fc fragment 
of Gm(b+) Vi myeloma (Gla); and  Fig. 3 b, naturally  occurring Fc fragment  (Zuc) from 
patient  with heavy chain disease. Both of these show the presence of the "non-a"  peptide 
(~__) and absence of the "a" peptide (O). The arrows point to the region of variability in the 
basic peptides which generally allows them to be distinguished from maps prepared from We 
proteins. 726  HUMAN  "yG-MYELOMA  PROTEINS 
DISCUSSION 
The conclusions drawn from previous studies (13-15) of chemical differences 
associated with different Gm factors (Gm(a) and Gm(b)) in normal Caucasian 
7G-globulins have been limited by the marked heterogeneity of these molecules 
and the subsequent discovery ot new genetic factors some of which, like Gm(f), 
FIG. 4.  Peptide map of the heavy  chain of a Gm(--) protein of the Ne group showing the 
presence of the "non-a" spot (L_-_!) and absence of the "a" spot (O). The basic peptides are 
poorly resolved and difficult to evaluate. The peptides marked X were derive] from the Fd 
fragment. 
are closely linked to Gm(b) in Caucasians (17, 18). Studies with myeloma pro- 
teins circumvent some of the ambiguities inherent in this  heterogeneity since 
any one myeloma protein contains only one of the four recognized subtypes of 
3' chains (11,  12) and carries only one of the major Gm factors (4, 7, 32).  The 
current studies of peptide maps of 38 such proteins  (including representatives 
of all  four antigenic  groups),  none  containing more  than  one  of  the  factors 
Gm(a),  Gm(b), or Gm(f), confirm the existence of a  Feptide characteristic of 
Gm(a+) 7G-immunoglobulin molecules.  However, the peptide thought to be FRANGIONE, FRANKLIN, ~UDENBERG, AND  KOSHLAND  727 
characteristic  of  Gm(b+)  qcG-globulin  was  found in  all  Gm(a--)  myeloma 
proteins of the We, Vi, and Ne subtypes, but not in three myeloma proteins of 
the Ge(7~d) type. Since all Gin(b+)  Caucasian subjects are also Gm(f+) and 
since the We Gin(f+) molecules probably make up more than 80 % of the total 
"non-a"  molecules of IgG of normal subjects, it seems likely that the major 
contributors to this "non-a"  spot in normal subjects were Gm(f+) molecules, 
while Gin(b+) molecules, belonging to the Vi subgroup, contributed to a lesser 
extent to this spot in peptide maps of normal ~,-globulins  (13-15). Further, the 
TABLE II 
Comparison of the Amino Acid Recoveries from "A" and "Non-A" Peptides 
Peptide .............................  "A" 
,-Chain...  We 
9rn  type  ....  a+ 
~urcc material 
Lys 
His 
Arg 
Met. sulfone 
Asp 
Thr 
Ser 
Glu 
Pro 
Gly 
Ala 
Val 
Leu 
Chu-Fc 
1.0 
0.18 
12 
1.1 
0.43 
1.4 
0.25 
0.44 
1.1 
"Non-A" 
We 
f+ 
Pre-Fc 
1.0 
0.33 
1.1 
0.28 
0.96 
0.28 
2.1 
0.20 
0.21 
0.25 
0.30 
Zuc-Fc 
1.0 
1.1 
0.15 
1.0 
0.17 
2.0 
0.23 
Vi 
b+ 
Gla-Fc 
1.0 
0.99 
0.41 
0.99 
0.24 
2.2 
0.36 
Ne 
Lew-H 
1.0 
0.35 
0.93 
0.54 
1.0 
0.38 
1.9 
0.12 
0.49 
0.30 
0.37 
0.24 
amino acid composition of the "non-a" spot was identical in all Gm(a-) mye- 
loma proteins belonging to the We('Y2b), Vi(~%),  or Ne(~%) subclass, whether 
positive for Gm(b), positive for Gin(f), or negative for both factors. Two of the 
five amino acid residues of the "non-a" spot (glutamic acid and methionine) 
differed from the residues in the "a" peptide (aspartic acid and leucine). Thus, 
these studies show that the single peptide difference previously observed can 
distinguish only between Gin(a+) and Gin(a-) globulins belonging to three of 
the subclasses.  Independently of the work presented here, Thorpe and Deutsch 
(30)  have isolated the "a" and "non-a" peptides from two We myeloma pro- 
teins and determined their sequence. Their findings, and the amino acid com- 
positions reported above, are in excellent agreement. 
In addition, these studies of myelonm proteins furnish new information on 728  nuJ~IAN '~G-~EYELOMA PROTEINS 
several points. Firstly, the "non-a" spots in the peptide maps of Fc fragments 
and heavy chains do not readily distinguish  between Gm(bA-) and (f-b) pro- 
teins, thus suggesting  strongly that the "non-a" peptide is not responsible  for 
the serologic specificity.  Since Gin(f) activity is localized to the Fd fragment of 
the heavy chain while Gin(b) resides in the Fc fragment (9), it seems possible 
that  a  peptide characteristic of Gin(f) activity may, indeed,  occur in the Fd 
fragment, but the marked variability of this portion of the chain renders identi- 
fication of this specific peptide extremely difficult. In the case of Gin(b), a pep- 
tide characteristic of Gin(b) activity would be expected to e~ist in the Fc frag- 
ment and, indeed,  may be present in the variable basic spots in the bottom of 
the map which distinguish We proteins from Vi molecu]es,  but do not readily 
lend themselves to accurate interpretation;  or it may reside  elsewhere  in the 
peptide map, but obscured by other peptides. 
Another  possibility is  that  the  peptide  characteristic  of  Gin(b)  activity 
arises  from a sequence of the five amino acids,  different from that present in 
the Gin(b--) "non-a" peptides. However, this interpretation would require at 
least three different sequences for the "non-a" peptides, one for  the  Fc frag- 
ment from Gm(f+)  We('y~b) proteins, one for the Fc fragment for  Gm(b+) 
Vi('y2,) proteins,  and one or more for the Fc fragment from Gin(b-f--) pro- 
teins of the Vi('y2c) and perhaps of the Ne('y~) subclass. Therefore, an explana- 
tion based on identical amino acids arranged in different sequence seems im- 
probable, and it seems unlikely that  this  peptide is responsible for serologic 
specificity. Information on the sequences of all these pepfides is currently not 
available since Thorpe and Deutsch (30) have reported the sequence of the "a" 
spot and the "non-a" spot only from a  Gin(f+)  protein,  but  have  not  yet 
studied this peptide from a Gin(b+) or a Gin(b--f--) protein. 
The second type of information revealed by peptide mapping of the myeloma 
protein Fc fragments are the differences correlated with the antigenic subclasses. 
In general,  there were striking similarities  in the majority of the peptides in all 
four classes currently described.  For example, maps of all We(q'2b) Fc fragments 
were very similar  except for the single peptide difference between Gin(a+) and 
Gin(f+) myeloma proteins discussed above, and some minor variability in the 
middle of the map.  Maps from the Fc fragments of Vi('y2,) proteins differed 
from the Gin(f+) We molecules only in a group of basic peptides at the bottom 
of the map. Studies on proteins of the Ne('y~,) type were limited because of the 
small number of pure samples available. However, in general,  the peptide maps 
resembled those of We Gin(f+)  molecules.  Of special  interest is the striking 
difference in the peptide maps of three Ge('ym) type Fc fragments which lack 
several peptides characteristic  of the  other  three  classes.  Though  additional 
examples are necessary to confirm  this observation, the data suggest that the 
Ge subgroup differs strikingly from the others. Since Ge proteins appear to be 
of more rapid mobility, the Ge group is perhaps analogous to the "yl-fraction 
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Thirdly, minor differences were observed in Fc fragments belonging to the 
same class, which might perhaps be related to unknown Gm classes or to intra- 
class variation on another basis. These  were most striking in the case of the 
Vi(3'2c) molecules which are also most heterogeneous by serologic tests.  How- 
ever,  some variability was also noted in certain peptides  within each of the 
other three subgroups. Whether these reflect true structural differences or pos- 
sibly artifacts of the fingerprinting technique remains to be determined. 
Sufficient data are not yet available to permit detailed interpretations of the 
observed structural differences related to the Gm factors.  Comparison  of the 
amino acid composition  and sequence of the "a" spot with that of "non-a" 
spots shows similarities in three of the amino acids (lysine, threonine,  and one 
residue of glutamic acid), and the replacement of an aspartic acid or asparagine 
and a leucine residue in the "a" spot by a methionine residue and a giutamic 
acid or glutamine in the "non-a" spots. The possibility exists that these changes 
may be the result of point mutations of a structural gene,  as is the case for 
hemoglobins (34). However, in the absence of definitive proof for such a mech- 
anism,  alternative possibilities must be considered.  Among these is the possi- 
bility that the two pepfides are derived from each other by other mechanisms 
recently thought to account for the variability in antibody structure, e.g. non- 
homologous crossing over,  unequal homologous crossing over, interchromatid 
inversion with reversed  complementarity (35, 36), insertion of inactive DNA 
(37), and possibly other mechanisms. Another possibility which may explain 
the existence of at least three nucleofide substitutions is the possibility that the 
"a" and "non-a" pepfides are not directly related but have evolved from each 
other through a number of intermediate stages which remain to be identified. 
Further speculation seems unwarranted until the amino acid sequence of the 
pertinent pepfides is known and the precise mode of inheritance of these factors 
is fully elucidated. 
SUMMARY 
1. Peptide maps of Fc fragments or heavy chains of 36 G myeloma proteins 
and two "heavy chain disease"  proteins belonging  to the four ~/-chain sub- 
groups revealed very striking similarities  between them. However  differences 
in a few peptides  were noted. This was most pronounced for the Ge('},2d) sub- 
group which lacked three peptides characteristic  of the other three subgroups. 
While  Fc fragments from different proteins belonging to the same subgroup 
appeared very similar, minor differences in addition to those based on currently 
recognized Gm factors were occasionally noted. 
2.  Fc fragments from Gm(aq-) We(')',b) proteins had a pepfide previously 
shown to be characteristic of normal Gm(aq-) "},G-globulins. Fc fragments from 
Gin(a--) molecules belonging to the We(h,~b), Vi(3'~c), or Ne(~,~a) subgroups, 
whether Gm(b-b), Gin(f-{-), or Gin(-), had the peptide previously identified 
in Gm(b-{-f-{-) normal "rG-globulin. This "non-a" pepfide was absent in pep- 730  HUMAN  ~G-MYELOMA  PROTEINS 
tide maps from Gm(--) molecules of the Ge(7~d) subgroup which contained in- 
stead  another peptide  with  the  same electrophoretic  mobility but  migrating 
slightly further on chromatography. 
3.  Both  the  "a"  and  "non-a"  peptides  were  pentapeptides  having  three 
amino acids in common, and differing in the other two. The "a" peptide con- 
tained  one  residue  of lysine,  aspartic  acid,  threonine,  leucine,  and  glutamic 
acid.  The  "non-a"  peptides  prepared from Gin(b+),  Gin(f+),  and  Gin(--) 
proteins  were  identical  and  contained  one  residue  of lysine,  threonine,  and 
methionine sulfone, and two residues of glutamic acid. 
4.  Several possible mechanisms for the origin of these differences, and their 
possible role in serologic specificity are discussed. 
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